CytoSorbents Corporation (NASDAQ: CTSO) announced that it has received European Union regulatory approval to expand the use of CytoSorb to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA Management Comments

CytoSorbents (CTSO) PT Raised to $13 at Maxim GroupMay 14, 2018 1:23 PM CytoSorb® Adds Bilirubin and Myoglobin Reduction to European Union Approved Indications for UseMay 14, 2018 7:08 AM